| Today's Open | $4.10 |
|---|---|
| Previous Close | $4.05 |
| Daily Range | $3.97 - $4.10 |
| 52-Week Range | $3.69 - $7.94 |
| Market Cap | $646.2M |
| P/E Ratio | -1.67 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 2,360,313 |
| Average Daily Volume | 4,650,309 |
| Current FY EPS | -$1.60 |
Sector
Healthcare
Industry
Drugs
Dendreon Corp (DNDN) Description
A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. Website: http://www.dendreon.com/
News & Commentary
One Person's Trash Is Another Person's Treasure Portfolio
A yearlong exercise intent on proving that value and contrarian investing can be incredibly successful.3 Reasons You Shouldn't Buy Stocks in Biotech
Wondering if you should buy stocks in biotech? Here are 3 reasons why you might want to take a pass.Why Progenics Is Poised to Plunge
Market-lagging returns could be written in this 2-star stock.Pre-Market Most Active for May 31, 2013 : BAC, NOK, SPIL, BBRY, AL, RDS/A, ING, DNDN, SIRI, NBG, OV
Pre-Market Most Active for May 31, 2013 : BAC, NOK, SPIL, BBRY, AL, RDS/A, ING, DNDN, SIRI, NBG, OVTI, FBDNDN's Top Competitors
(1.23%)
(1.70%)
(-2.30%)
(-2.00%)